Applied Molecular Transport Inc.

Applied Molecular Transport Inc. (AMTI) priced its initial public offering on Jun 5, 2020 at $14.00 per share, within its $12.00–$14.00 range, raising $154M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $453.6M. BofA Securities was lead-left underwriter, joined by Jefferies and Leerink Partners. Wilson Sonsini advised the company and Cooley advised the underwriters.

Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company developing oral biologic product candidates for autoimmune, inflammatory, metabolic and other diseases. Its platform uses natural cellular trafficking pathways to move therapeutic payloads across the intestinal epithelium, in tablet and capsule forms.

Status

IPO

Ticker

AMTI

Exchange

Nasdaq Global Select

Priced

Jun 5, 2020

IPO price

$14.00

Price range

$12.00–$14.00

Raised

$154M

Market cap at IPO price

$453.6M

First filed

May 18, 2020

Underwriters

BofA Securities, Jefferies and Leerink Partners

Company counsel

Wilson Sonsini

Underwriters' counsel

Cooley

Sector

Biotech & pharma

Country / state

DE

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.